Neurons, operating as Neurons Inc with its AI product line called Neurons AI, builds neuromarketing software that predicts how an audience will respond to advertising creative before it runs. The company was founded in 2013 by neuroscientist Dr. Thomas Zoëga Ramsøy and Mike Storm, and is headquartered in Copenhagen, Denmark.
Neurons' predictions are trained on eye-tracking and brain-scanning data the company has collected from roughly 300,000 participants over two decades of neuroscience research, rather than on generic ad-performance datasets. Marketers upload a creative, an image, video, or full campaign, and the AI predicts attention patterns, emotional response, and brand recall, which the company reports at above 95% accuracy against real human testing, letting teams catch weak creative before a media budget is spent on it.
Neurons AI suits brand and performance marketing teams at agencies and larger advertisers who run enough paid creative to justify pre-testing, rather than small businesses running one-off local ads. Pricing is not published and is quoted after a short qualification conversation about an organization's testing volume and needs; the company has raised more than $6.6 million in seed funding.
